1. Abbas M.M., Xu Z., Tan L.C.S. (2018). Epidemiology of Parkinson's disease East versus West. Movement Disorders Clinical Practice, 5, 1, 1428.
2. Baldereschi M., Di Carlo A., Vanni P., Ghetti A., Carbonin P., Amaducci L., Inzitari D. (2003). Lifestyle related risk factors for Parkinson's disease: a population based study. Acta Neurologica Scandinavica, 108, 4, 239244.
3. Ball N., Teo W-P., Chandra S., Chapman J. (2019). Parkinson's disease and the environment. Frontiers in Neurology, 10, 218, 18.
4. Bettiol S.S., Rose T.C., Hughes C.J., Smith L.A. (2015). Alcohol consumption and Parkinsons disease risk: A review of recent findings. Journal of Parkinson's Disease, 5, 3, 425442.
5. Bousquet M., Calon F., Cicchetti F. (2011). Impact of omega-3 fatty acids in Parkinson's dis-ease. Ageing Research Reviews, 4, 4, 453463.
6. Chan D.K.Y., Jwoob J., Hoc S.C., Pangd C.P., Lawd L.K., Nge P.W., Hungf W.T., Kwokb T., Huig H., Orrg K., Leunge M.F., Kayb R. (1998). Genetic and environmental risk factors for Parkinsons disease in a Chinese population. Journal of Neurology, Neurosurgery & Psychiatry, 65, 5, 781784.
7. Chan K.L. (2017). Intelligence capital index. Available at: http://www.kailchan.ca/wp-content/uploads/2017/04/KC_Intelligence-Capital-Index-full-results-and-methodology_Apr-2017_v2.pdf
8. Checkoway H., Powers K., Smith-Weller T., Franklin G.M., Longstreth W.T. Jr., Swan-son P.D. (2002). Parkinson's disease risks associated with cigarette smoking, alcohol con-sumption, and caffeine intake. American Journal of Epidemiology, 155, 8, 732738.
9. Chinta S.J., Lieu C.A., DeMaria M., Laberge R.M., Campisi J., Andersen J.K. (2013). Envi-ronmental stress, ageing and glial cell senescence: A novel mechanistic link to Parkinson's disease? Journal of Internal Medicine, 273, 5, 429436.
10. Frigerio R., Elbaz A., Sanft K.R., Peterson B.J., Bower J.H., Ahlskog J.E., Grossardt B.R., Andrade M., Maraganore D.M., Rocca W.A. (2005). Education and occupations preceding Parkinson disease: A population-based case-control study. Neurology, 65, 10, 15751583.
11. Gao X., Chen H., Fung T.T., Logroscino G., Schwarzschild M.A., Hu F.B., Ascherio A. (2007). Prospective study of dietary pattern and risk of Parkinson disease. The American Journal of Clinical Nutrition, 86, 5, 14861494.
12. Hernan M.A., Takkouche B., Caamano-Isorna F., Gestal-Otero J.J. (2002). A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinsons disease. Annals of Neurology, 52, 3, 276284.
13. Kaiyrzhanov R., Rizig M., Aitkulova A., Zharkinbekova N., Shashkin C., Kaishibayeva G., Karimova A., Khaibullin T., Sadykova D., Ganieva M., Rasulova K., Houlden H. (2019). Parkinsons disease in Central Asian and Transcaucasian Countries: A review of epidemiology, genetics, clinical characteristics, and access to care. Parkinsons Disease. Available at: https://www.hindawi.com/journals/pd/2019/2905739/
14. Levin O.S., Fedorova N.V. (2014). Parkinson's disease. Moscow: Medpress-Inform (in Rus-sian).
15. Li X., Sundquist J., Sundquist K. (2009). Socioeconomic and occupational groups and Parkin-sons disease: a nationwide study based on hospitalizations in Sweden. International Arc-hives of Occupational and Environmental Health, 82, 2, 235241.
16. Liu R., Guo X., Park Y., Wang J., Huang X., Hollenbeck A., Blair A., Chen H. (2013). Alcohol consumption, types of alcohol, and Parkinsons disease. Plos One, 8, 6, 17.
17. Lu K.T., Ko M.C., Chen B.Y., Huang J.C., Hsieh C.W., Lee M.C.., Chiou R.Y., Wung B.S., Peng Ch.H., Yang Y.L. (2008). Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. Journal of Agricultural and Food Chemi-stry, 56, 16, 69106913.
18. Mischley L.K., Lau R.C., Bennett R.D. (2017). Role of diet and nutritional supplements in Parkinsons disease progression. Oxidative Medicine and Cellular Longevity. Available at: http://downloads.hindawi.com/journals/omcl/2017/6405278.pdf
19. Morens D.M., Grandinetti A., Davis J.W., Ross W., White L.R., Reed D. (1996). Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease. American Journal of Epi-demiology, 144, 4, 400404.
20. Nielsen S., Franklin G.M., Longstreth W.T., Swanson P.D., Checkoway H. (2013). Nicotine from edible solanaceae and risk of Parkinson disease. Annals of Neurology, 74, 3, 472477.
21. Okubo H., Miyake Y., Sasaki S., Murakam K., Tanaka K., Fukushima W., Kiyohara C., Tsuboi Y., Yamada T., Oeda T., Shimada H., Kawamura N., Sakae N., Fukuyama H., Hirota Y., Nagai M., Kinki F. (2012). Dietary patterns and risk of Parkinsons disease: A case-control study in Japan. European Journal of Neurology, 19, 5, 681688.
22. Osaki Y., Morita Y., Kuwahara T., Miyano I., Doi Y. (2010). Prevalences of Parkinson's dis-ease and atypical parkinsonian syndromes in a rural Japanese area. European Journal of Neurology, 124, 3, 182187.
23. Peters C.M., Gartner C.E., Silburnb P.A., Mellick G.D. (2006). Prevalence of Parkinsons disease in metropolitan and rural Queensland: A general practice survey. Journal of Ñlinical Neuroscience, 13, 3, 343348.
24. Pressley J.C., Tang M.X., Marder K., Cote L.J., Mayeux R. (2005). Disparities in the record-ing of Parkinson's disease on death certificates. Movement Disorders, 20, 3, 315321.
25. Ritz B., Ascherio A., Checkoway H., Marder K.S., Nelson L.M., Rocca W.A., Ross G.W., Strickland D., Van Den Eeden S.K., Gorell J. (2007). Pooled analysis of tobacco use and risk of Parkinson disease. Archives of Neurology, 64, 7, 990997.
26. Saaksjarvi K., Knekt P., Rissanen H., Laaksonen M.A., Reunanen A., Mannisto S. (2008). Prospective study of coffee consumption and risk of Parkinsons disease. European Journal of Clinical Nutrition, 62 (7), 908915.
27. Seidl S.E., Santiago J.A., Bilyk H., Potashkin J.A. (2014). The emerging role of nutrition in Parkinson's disease. Frontiers in Aging Neuroscience, 6, 36. Available at:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945400/
28. Shih I.F., Liew Z., Krause N., Ritz B. (2016). Lifetime occupational and leisure time physical activity and risk of Parkinson's disease. Parkinsonism & Related Disorders, 28, 112117.
29. Tan L.C., Koh W.P., Yuan J.M., Wang R., Au W.L., Tan J.H., Tan E.K., Mimi C.Y. (2007). Differential effects of black versus green tea on risk of Parkinsons disease in the Singapore Chinese health study. American Journal of Epidemiology, 167, 5, 553560.
30. Wanneveich M., Moisan E., Jacqmin-Gadda H., Elbaz A., Joly P. (2018). Projections of pre-valence, lifetime risk, and life expectancy of Parkinson's disease (20102030) in France. Movement Disorders, 33, 9, 14491455.
31. Willis A.W., Evanoff B.A., Lian M., Galarza A., Wegrzyn A., Schootman M., Racette B.A. (2010). Metal emissions and urban incident Parkinson disease: A community health study of Medicare beneficiaries by using geographic information systems. American Journal of Epidemiology, 172, 12, 13571363.
32. Winter Y., Campenhausen S., Popov G., ReeseJ., Balzer-Geldsetzer M., Kukshina A., Zhu-kova T. Bertschi N., Botzel K., Gusev E., Oertel W., Dodel R., Guekht A. (2010) Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study. Parkinsonism & Related Disorders, 16, 4, 243248.
33. Wirdefeldt K., Gatz M., Pawitan Y., Pedersen N. (2005). Risk and protective factors for Par-kinson's disease: A study in Swedish twins. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society, 57, 1, 2733.
34. Yang F., Johansson A.L.V., Pedersen N.L., Fang F., Gatz M., Wirdefeldt K. (2016). Socioe-conomic status in relation to Parkinson's disease risk and mortality: A population-based prospective study. Medicine, 95, 30, 16.
35. Yang X.L., Luo Q., Song H.X., Wang Y.L., Yao Y.N., Xia H. (2015). Related factors and pre-valence of Parkinsons disease among Uygur residents in Hetian, Xinjiang Uygur Autonomous Region. Genetics and Molecular Research, 14, 3, 85398546.
Comments
No posts found